On top of Humira, this is a pretty good bet on oral RA drugs IMO.
Let’s not get ahead of ourselves—so far, ABT has merely acquired an option on Galapagos’ drug. I’m very long ABT and would like this program to succeed, but even expensive options such as this one get declined sometimes.
Market Data 
Markets 
AI
